MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 563 SEK 3.68% Market Closed
Market Cap: 8.3B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MedCap AB (publ)
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Cash & Cash Equivalents
kr287.7m
CAGR 3-Years
29%
CAGR 5-Years
76%
CAGR 10-Years
15%
AddLife AB
STO:ALIF B
Cash & Cash Equivalents
kr272m
CAGR 3-Years
8%
CAGR 5-Years
35%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash & Cash Equivalents
kr861m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cash & Cash Equivalents
kr370m
CAGR 3-Years
1%
CAGR 5-Years
23%
CAGR 10-Years
17%
G
Genovis AB
STO:GENO
Cash & Cash Equivalents
kr135.8m
CAGR 3-Years
48%
CAGR 5-Years
72%
CAGR 10-Years
41%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash & Cash Equivalents
kr7.1m
CAGR 3-Years
5%
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

MedCap AB (publ)
Glance View

Market Cap
8.3B SEK
Industry
Life Sciences Tools & Services

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

MCAP Intrinsic Value
423.54 SEK
Overvaluation 25%
Intrinsic Value
Price

See Also

What is MedCap AB (publ)'s Cash & Cash Equivalents?
Cash & Cash Equivalents
287.7m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Cash & Cash Equivalents amounts to 287.7m SEK.

What is MedCap AB (publ)'s Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
15%

Over the last year, the Cash & Cash Equivalents growth was 48%. The average annual Cash & Cash Equivalents growth rates for MedCap AB (publ) have been 29% over the past three years , 76% over the past five years , and 15% over the past ten years .

Back to Top